deguelin has been researched along with docetaxel anhydrous in 2 studies
Studies (deguelin) | Trials (deguelin) | Recent Studies (post-2010) (deguelin) | Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) |
---|---|---|---|---|---|
182 | 0 | 115 | 12,110 | 3,216 | 6,920 |
Protein | Taxonomy | deguelin (IC50) | docetaxel anhydrous (IC50) |
---|---|---|---|
Kinesin-like protein KIF11 | Homo sapiens (human) | 0.0014 | |
Nucleotide-binding oligomerization domain-containing protein 2 | Homo sapiens (human) | 5.0119 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
Ates, H; Cengiz, H; Kocdor, H; Kocdor, MA | 1 |
2 other study(ies) available for deguelin and docetaxel anhydrous
Article | Year |
---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Inhibition of Cancer Stem-Like Phenotype by Curcumin and Deguelin in CAL-62 Anaplastic Thyroid Cancer Cells.
Topics: AC133 Antigen; Apoptosis; Cell Cycle; Cell Line, Tumor; Curcumin; Docetaxel; Drug Therapy, Combination; Humans; Nanog Homeobox Protein; Neoplastic Stem Cells; Octamer Transcription Factors; Oxidative Stress; Phenotype; Rotenone; Superoxide Dismutase; Thy-1 Antigens; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms | 2019 |